A Clinical Study of Non-curative Resection Plus Radiotherapy After Endoscopic ESD for Superficial Esophageal Squamous Cell Carcinoma
NCT06160557 · Status: ENROLLING_BY_INVITATION · Type: OBSERVATIONAL · Enrollment: 40
Last updated 2024-01-03
Summary
The goal of observational study is to learn about the outcomes of the participants. The main questions it aims to answer are:
1. ESD additional postoperative radiotherapy in patients with non healing SESCC overall survival (OS) and disease-free survival (DFS)
2. The adverse events (AE) of additional radiotherapy after ESD for non-curative SESCC patients were counted, and its safety was evaluated.
Participants will receive radiation therapy as necessary.
Conditions
- Esophagus Cancer
- Radiotherapy
- Endoscopic Mucosal Resection
Sponsors & Collaborators
-
Xiaomeng Zheng
lead OTHER
Eligibility
- Min Age
- 18 Years
- Max Age
- 75 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2023-11-29
- Primary Completion
- 2027-06-01
- Completion
- 2027-12-01
Countries
- China
Study Locations
More Related Trials
-
Radiotherapy Combined With Immunochemotherapy in Metastatic Esophageal Squamous Cell Carcinoma
NCT05978193 ·Status: RECRUITING ·Phase: PHASE2
-
Endoscopic Submucosal Dissection Versus Esophagectomy for Early Esophageal Carcinoma
NCT06060106 ·Status: COMPLETED
-
A Study of IO Plus Radiotherapy in Patients With Advanced ESCC.
NCT05760391 ·Status: RECRUITING ·Phase: NA
-
A Study of SBRT for OligoMetastatic ESCC
NCT03000816 ·Status: COMPLETED ·Phase: NA
-
Multicenter Cohort Study of ESD and Chemo-radiotherapy for High-risk Early-stage Esophageal Cancer
NCT06385717 ·Status: RECRUITING
-
Neoadjuvant Anti-PD-1 Plus Chemotherapy in Locally Advanced Resectable Esophageal Squamous Cell Carcinoma
NCT05740995 ·Status: RECRUITING
-
Postoperative Chemoradiation in Patients With Node-positive Esophageal Squamous Cell Carcinoma
NCT02446574 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Phase II Study of Postoperative Concurrent Chemoradiotherapy for Esophageal Squamous Cell Carcinoma (ESO- Shanghai 17)
NCT04764227 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Neoadjuvant Immunotherapy Combined With Chemotherapy in Patients With Locally Advanced ESCC
NCT05807542 ·Status: COMPLETED ·Phase: PHASE2
-
Induction Tislelizumab Combined With Chemotherapy Followed by Definitive Chemoradiotherapy in the Treatment of Locally Unresectable Esophageal Squamous Cell Carcinoma
NCT05515315 ·Status: RECRUITING ·Phase: PHASE2
-
Phase III Study of Concurrent Radiotherapy in Elderly Patients With Esophageal Squamous Cell Carcinoma (ESO-Shanghai 15)
NCT04519905 ·Status: RECRUITING ·Phase: NA
-
Watch and Wait for NeoAdjuvant Concurrent Radiochemotherapy Combined With Camrelizumab in Patients With Resectable ESCC
NCT05507411 ·Status: RECRUITING ·Phase: PHASE2
-
Study of Simultaneous Modulated Accelerated Radiation Therapy Concurrent With Chemotherapy to Treat Esophageal Cancer
NCT01670409 ·Status: COMPLETED ·Phase: PHASE2
-
Local Therapy for Oligorecurrent and Oligometastatic Esophageal Squamous Cell Carcinoma
NCT03904927 ·Status: COMPLETED ·Phase: PHASE2
-
DCRT vs. Surgery in Resectable ESCC Patient Achiving cCR/PR After nCI
NCT07162506 ·Status: RECRUITING ·Phase: PHASE2
-
Monitoring Efficacy of Radiotherapy in Lung Cancer and Esophageal Cancer
NCT04014465 ·Status: UNKNOWN
-
Camrelizumab Combined With Radiotherapy for Adjuvant Treatment of Esophageal Squamous Cell Carcinoma After Surgery
NCT04741490 ·Status: UNKNOWN ·Phase: NA
-
Neoadjuvant Immunotherapy Plus CRT Versus Neoadjuvant CRT for Locally Advanced Resectable ESCC
NCT04973306 ·Status: RECRUITING ·Phase: PHASE2/PHASE3
-
Synchronous or Sequential Radiotherapy for Advanced Esophageal Squamous Cell Carcinoma With Oligometastases.
NCT06143722 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Comparison of Esophagectomy and Chemoradiation for Patients With cN0-pT1b Stage Esophageal Squamous Cell Carcinoma
NCT04135664 ·Status: RECRUITING ·Phase: PHASE3
-
Report of the Survival Outcomes of Patients With Esophageal Cancer After Definitive Radiotherapy in China
NCT05194371 ·Status: COMPLETED
-
Comparing 61.2 Gy Radiotherapy Dose Versus 50.4 Gy Radiotherapy Dose for Locally Advanced Esophageal Carcinoma
NCT03790553 ·Status: UNKNOWN ·Phase: PHASE3
-
Neoadjuvant Immunotherapy (PD-1 / PD-L1) Combined With Chemotherapy for Locally Advanced Thoracic Esophageal Squamous Cell Carcinoma: a Single Center, Prospective, Open, One Arm Exploratory Clinical Study
NCT05028231 ·Status: UNKNOWN
-
Real-world Study on Comprehensive Treatment of Esophageal Cancer Based on Precision Radiotherapy
NCT05543057 ·Status: RECRUITING
-
Ivonescimab Plus Short-Course Hypofractionated Radiotherapy as Second-Line Therapy for Esophageal Squamous Cell Carcinoma
NCT07188103 ·Status: RECRUITING ·Phase: PHASE2